litlas
ログインアカウント作成

Shridar Ganesan

1990–2025 年に発表

113
論文数
18,921
被引用数
64
h 指数
108
i10 指数

被引用数

Shridar Ganesan の年別被引用数1982 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 2 件1992 年: 被引用 5 件1993 年: 被引用 5 件1994 年: 被引用 3 件1995 年: 被引用 2 件1996 年: 被引用 10 件1997 年: 被引用 11 件1998 年: 被引用 16 件1999 年: 被引用 11 件2000 年: 被引用 25 件2001 年: 被引用 58 件2002 年: 被引用 79 件2003 年: 被引用 98 件2004 年: 被引用 106 件2005 年: 被引用 109 件2006 年: 被引用 119 件2007 年: 被引用 149 件2008 年: 被引用 139 件2009 年: 被引用 156 件2010 年: 被引用 212 件2011 年: 被引用 246 件2012 年: 被引用 196 件2013 年: 被引用 237 件2014 年: 被引用 246 件2015 年: 被引用 245 件2016 年: 被引用 256 件2017 年: 被引用 247 件2018 年: 被引用 300 件2019 年: 被引用 725 件2020 年: 被引用 772 件2021 年: 被引用 814 件2022 年: 被引用 717 件2023 年: 被引用 571 件2024 年: 被引用 752 件2025 年: 被引用 404 件2026 年: 被引用 27 件1983〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,284 件、この内訳の 30.1%中国: 引用元論文 1,305 件、この内訳の 12%イギリス: 引用元論文 782 件、この内訳の 7.2%イタリア: 引用元論文 411 件、この内訳の 3.8%ドイツ: 引用元論文 410 件、この内訳の 3.7%フランス: 引用元論文 370 件、この内訳の 3.4%カナダ: 引用元論文 363 件、この内訳の 3.3%インド: 引用元論文 294 件、この内訳の 2.7%日本: 引用元論文 293 件、この内訳の 2.7%オランダ: 引用元論文 292 件、この内訳の 2.7%スペイン: 引用元論文 255 件、この内訳の 2.3%オーストラリア: 引用元論文 247 件、この内訳の 2.3%
0%30.1%その他 23.8%

機関

分野

  • Biochemistry, Genetics and Molecular Biology44%
  • Medicine34.3%
  • Computer Science15.7%
  • Immunology and Microbiology2.1%
  • Agricultural and Biological Sciences1.3%
  • Engineering0.8%
  • その他1.8%

トピック

  • DNA Repair Mechanisms7%
  • AI in cancer detection5.5%
  • PARP inhibition in cancer therapy3.8%
  • Radiomics and Machine Learning in Medical Imaging3.2%
  • CRISPR and Genetic Engineering3.1%
  • Cancer Genomics and Diagnostics2.8%
  • その他74.6%

共著者

全論文

検索で開く
  1. Understanding and overcoming resistance to PARP inhibitors in cancer therapy

    著者: Mariana Paes Dias, Sarah C. Moser, Shridar Ganesan, Jos Jonkers - Nature Reviews Clinical Oncology 2021 被引用: 487

  2. Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent

    著者: Ángel Cruz-Roa, Hannah Gilmore, Ajay Basavanhally, Michael D. Feldman, Shridar Ganesan, Natalie Shih, John Tomaszewski, Fabio A. González, Anant Madabhushi - Scientific Reports 2017 被引用: 542

  3. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

    著者: Matteo Palmeri, Janice M. Mehnert, Ann W. Silk, Salma K. Jabbour, Shridar Ganesan, Pallvi Popli, Gregory Riedlinger, Ryan D. Stephenson, Alexandre Buckley de Meritens, Aliza Leiser, Tina Mayer, Nancy Chan, Kristen Spencer, Eugenia Girda, Jyoti Malhotra, Timothy A. Chan, Vivek Subbiah, Roman Groisberg - ESMO Open 2021 被引用: 353

  4. Automatic detection of invasive ductal carcinoma in whole slide images with convolutional neural networks

    著者: Angel Cruz-Roa, Ajay Basavanhally, Fabio A. González, Hannah Gilmore, Michael D. Feldman, Shridar Ganesan, Natalie Shih, John Tomaszewski, Anant Madabhushi - SPIE, Digital Pathology 2014 被引用: 588

  5. Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion

    著者: Debyani Chakravarty, Amber Johnson, Jeffrey Sklar, Neal I. Lindeman, Kathleen Moore, Shridar Ganesan, Christine M. Lovly, Jane Perlmutter, Stacy W. Gray, Jimmy Hwang, Christopher Lieu, Fabrice André, Nilofer Azad, Mitesh Borad, Laura Tafe, Hans Messersmith, Mark Robson, Funda Meric-Bernstam - Journal of Clinical Oncology 2022 被引用: 249

  6. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

    著者: Peter Bouwman, Amal Aly, José Miguel Escandell, Mark Pieterse, Jiřina Bártková, Hanneke van der Gulden, Sanne Hiddingh, Maria Thanasoula, Atul Kulkarni, Qifeng Yang, Bruce G. Haffty, Johanna Tommiska, Carl Blomqvist, Ronny Drapkin, David J. Adams, Heli Nevanlinna, Jiří Bártek, Madalena Tarsounas, Shridar Ganesan, Jos Jonkers - Nature Structural & Molecular Biology 2010 被引用: 1,021

  7. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma

    著者: Christof C. Smith, Kathryn E. Beckermann, Dante S. Bortone, Aguirre A. de Cubas, Lisa M. Bixby, Samuel Lee, Anshuman Panda, Shridar Ganesan, Gyan Bhanot, Eric Wallen, Matthew I. Milowsky, William Y. Kim, W. Kimryn Rathmell, Ronald Swanstrom, Joel S. Parker, Jonathan S. Serody, Sara R. Selitsky, Benjamin G. Vincent - Journal of Clinical Investigation 2018 被引用: 310

  8. Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors

    著者: Janneke E. Jaspers, Ariena Kersbergen, Ute Boon, Wendy Sol, Liesbeth van Deemter, Serge A.L. Zander, Rinske Drost, Ellen Wientjens, Jiuping Ji, Amal Aly, James H. Doroshow, Aaron Cranston, Niall M.B. Martin, Alan Lau, Mark J. O’Connor, Shridar Ganesan, Piet Borst, Jos Jonkers, Sven Rottenberg - Cancer Discovery 2012 被引用: 515

  9. Emerging strategies for treating metastasis

    著者: Mark Esposito, Shridar Ganesan, Yibin Kang - Nature Cancer 2021 被引用: 164

  10. Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers

    著者: Cheng Lu, David Romo‐Bucheli, Xiangxue Wang, Andrew Janowczyk, Shridar Ganesan, Hannah Gilmore, David L. Rimm, Anant Madabhushi - Laboratory Investigation 2018 被引用: 164

  11. Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer

    著者: Mridula George, Sadaf Qureshi, Coral Omene, Deborah Toppmeyer, Shridar Ganesan - Frontiers in Oncology 2021 被引用: 149

  12. Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer

    著者: Jon Whitney, Germán Corredor, Andrew Janowczyk, Shridar Ganesan, Scott Doyle, John Tomaszewski, Michael D. Feldman, Hannah Gilmore, Anant Madabhushi - BMC Cancer 2018 被引用: 112

  13. Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma

    著者: Anshuman Panda, Aguirre A. de Cubas, Mark N. Stein, Gregory Riedlinger, Joshua Kra, Tina Mayer, Christof C. Smith, Benjamin G. Vincent, Jonathan S. Serody, Kathryn E. Beckermann, Shridar Ganesan, Gyan Bhanot, W. Kimryn Rathmell - JCI Insight 2018 被引用: 179

  14. High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection

    著者: Ángel Cruz-Roa, Hannah Gilmore, Ajay Basavanhally, Michael D. Feldman, Shridar Ganesan, Natalie Shih, John Tomaszewski, Anant Madabhushi, Fabio A. González - PLoS ONE 2018 被引用: 151

  15. Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

    著者: Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, Sjors M. Kas, Frank Rolfs, Catrin Lutz, Jessica Lee, Sjoerd Klarenbeek, Ian M. Silverman, Stefano Annunziato, Chang S. Chan, Sander R. Piersma, Timo Eijkman, Madelon Badoux, Ewa Gogola, Bjørn Siteur, Justin Sprengers, Bim de Klein, Richard R. de Goeij‐de Haas, Gregory Riedlinger, Hua Zhu Ke, Russell W. Madison, Anne Paulien Drenth, Eline van der Burg, Eva Schut, Linda Henneman, Martine H. van Miltenburg, Natalie Proost, Hui‐Ling Zhen, Ellen Wientjens, Roebi de Bruijn, Julian R. de Ruiter, Ute Boon, Renske de Korte‐Grimmerink, Bastiaan van Gerwen, Luis Féliz, Ghassan K. Abou‐Alfa, Jeffrey S. Ross, Marieke van de Ven, Sven Rottenberg, Edwin Cuppen, Anne Vaslin Chessex, Siraj M. Ali, Timothy C. Burn, Connie R. Jiménez, Shridar Ganesan, Lodewyk F.A. Wessels, Jos Jonkers - Nature 2022 被引用: 130

  16. Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response

    著者: Laura Poillet-Perez, Daniel W. Sharp, Yang Yang, Saurabh V. Laddha, Maria Ibrahim, Praveen K. Bommareddy, Zhixian Hu, Joshua A Vieth, Michael Haas, Marcus Bosenberg, Joshua D. Rabinowitz, Jian Cao, Jun‐Lin Guan, Shridar Ganesan, Chang S. Chan, Janice M. Mehnert, Edmund C. Lattime, Eileen White - Nature Cancer 2020 被引用: 111

  17. Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

    著者: Daniel P. Silver, Andrea L. Richardson, Aron C. Eklund, Zhigang C. Wang, Zoltán Szállási, Qiyuan Li, N. Juul, Chee-Onn Leong, Diana Calogrias, Ayodele Buraimoh, Aquila Fatima, Rebecca Gelman, Paula D. Ryan, Nadine Tung, Arcangela De Nicolo, Shridar Ganesan, Alexander Miron, Christian Colin, Dennis C. Sgroi, Leif W. Ellisen, Eric P. Winer, Judy E. Garber - Journal of Clinical Oncology 2010 被引用: 984

  18. Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

    著者: Janice M. Mehnert, Anshuman Panda, Judy Zhong, Kim M. Hirshfield, Sherri Damare, Katherine Lane, Levi Sokol, Mark N. Stein, Lorna Rodriguez-Rodriquez, Howard L. Kaufman, Siraj M. Ali, Jeffrey S. Ross, Dean C. Pavlick, Gyan Bhanot, Eileen White, Robert S. DiPaola, Ann Lovell, Jonathan D. Cheng, Shridar Ganesan - Journal of Clinical Investigation 2016 被引用: 385

  19. Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment

    著者: Verónica Rojas, Kim M. Hirshfield, Shridar Ganesan, Lorna Rodríguez-Rodríguez - International Journal of Molecular Sciences 2016 被引用: 262

  20. Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer

    著者: Anshuman Panda, Janice M. Mehnert, Kim M. Hirshfield, Gregory Riedlinger, Sherri Damare, Tracie Saunders, Michael P. Kane, Levi Sokol, Mark N. Stein, Elizabeth Poplin, Lorna Rodríguez-Rodríguez, Ann W. Silk, Joseph Aisner, Nancy Chan, Jyoti Malhotra, Melissa Frankel, Howard L. Kaufman, Siraj M. Ali, Jeffrey S. Ross, Eileen White, Gyan Bhanot, Shridar Ganesan - JNCI Journal of the National Cancer Institute 2017 被引用: 215

  21. Pan-cancer Analysis of Homologous Recombination Repair–associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score

    著者: C. Benedikt Westphalen, Alexander D. Fine, Fabrice André, Shridar Ganesan, Volker Heinemann, Etienne Rouleau, Clare Turnbull, Luis Garcia Palacios, Jorge-Antonio Lopez, Ethan S. Sokol, Joaquin Mateo - Clinical Cancer Research 2021 被引用: 80

  22. Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity

    著者: Ethan S. Sokol, Dean C. Pavlick, Hossein Khiabanian, Garrett M. Frampton, Jeffrey S. Ross, Jeffrey P. Gregg, Primo N. Lara, Steffi Oesterreich, Neeraj Agarwal, Andrea Necchi, Vincent A. Miller, Brian M. Alexander, Siraj M. Ali, Shridar Ganesan, Jon Chung - JCO Precision Oncology 2020 被引用: 181

  23. Computerized Image-Based Detection and Grading of Lymphocytic Infiltration in HER2+ Breast Cancer Histopathology

    著者: Ajay Basavanhally, Shridar Ganesan, Shannon Agner, James Monaco, Michael D. Feldman, John Tomaszewski, Gyan Bhanot, Anant Madabhushi - IEEE Transactions on Biomedical Engineering, IEEE Trans. Biomed. Eng. 2009 被引用: 267

  24. DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer

    著者: Aguirre A. de Cubas, William Dunker, Andrew Zaninovich, Rachel A. Hongo, Anuj Bhatia, Anshuman Panda, Kathryn E. Beckermann, Gyan Bhanot, Shridar Ganesan, John Karijolich, W. Kimryn Rathmell - JCI Insight 2020 被引用: 67